With so many advances and breakthroughs in thoracic oncology, the 2025 World Conference on Lung Cancer (WCLC) will feature not one, but two Presidential Symposia in Barcelona. Presidential Symposium 1 will take place today, Sunday, September 7, at 8:15 Central European Summer Time (CEST) in the Plenary Hall.
Paul Van Schil, MD, PhD, IASLC President, will chair this symposium, which will be the final Presidential Symposium of his term.
“Many excellent abstracts were submitted, and we had the difficult task of selecting the best ones for the Presidential Symposia. I think we could have even filled three symposia,” said Dr. Van Schil, Professor of Thoracic and Vascular Surgery, Antwerp University Faculty of Medicine. “These sessions highlight the latest international and multidisciplinary advances and developments in lung cancer.”
The first Presidential Symposium will focus on the latest advances in targeted therapies, featuring the following late-breaking abstract presentations:
- First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFR-mutant Advanced Non-Small Cell Lung Cancer (NSCLC): FLAURA2 Final Overall Survival
- Aumolertinib Plus Chemotherapy for NSCLC with EGFR and Concomitant Tumor Suppressor Genes (ACROSS 2): Phase III Study
- Ivonescimab versus Placebo Plus Chemo, Phase III in Patients with EGFR+ NSCLC Progressed with 3rd Gen EGFR-TKI Treatment: HARMONi
- Pivotal ARROS-1 Efficacy and Safety Data: Zidesamtinib in TKI-Pre-treated Patients with Advanced or Metastatic ROS1+ NSCLC
- Phase III Trial of Crizotinib versus Observation for Surgically Resected Early-Stage ALK+ NSCLC
Presidential Symposium 1 with Lectureship Award Presentations
8:15 CEST, Sunday, September 7 • Plenary Hall
The first Presidential Symposium will focus on the latest advances in targeted therapies. The session will also include the presentation of the Robert J. Ginsberg Lectureship Award for Surgery, the James D. Cox Lectureship Award for Radiation Oncology, and the 2025 IASLC Award for Tobacco Control and Smoking Cessation. LEARN MORE
In addition to showcasing novel data, the first Presidential Symposium will recognize “rising star” IASLC members for their contributions to the lung cancer community during the IASLC Lectureship Awards.
Andrea Wolf, MD, MPH, will receive the Robert J. Ginsberg Lectureship Award for Surgery. The James D. Cox Lectureship Award for Radiation Oncology will be presented to Suresh Senan, MRCP, FRCR, PhD. Additionally, the symposium will recognize Lawson Eng, MD, SM, FRCPC, as the 2025 IASLC Lectureship Award for Tobacco Control and Smoking Cessation recipient.
The second Presidential Symposium will take place Monday morning. Keep reading ILCN for additional details coming soon.
